全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2019 

New Medications in the Treatment of Acute Migraine

DOI: 10.1177/0018578719844701

Keywords: Investigational Drugs,Drug Information,Formulary Management/P & T,Neurology

Full-Text   Cite this paper   Add to My Lib

Abstract:

Migraine is a common disorder affecting 12% of the US population. Use of triptans results in migraine pain relief within 2 hours in 16% to 51% of patients. However, due to their vasoconstrictive properties, triptans are contraindicated in patients with cardiovascular disease, peripheral vascular disease, cerebrovascular disease, and uncontrolled hypertension because of the potential for ischemia. This article will review 2 new classes of drugs being developed for the treatment of acute migraine without vasoconstrictive effects

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133